A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout

NCT04956432 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

779

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: SHR4640
DRUG: Allopurinol

Sponsor

Jiangsu HengRui Medicine Co., Ltd.